Novavax

YTD

ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines.

CEO

John C.s Jacobs

CEOJohn C.s Jacobs

Employees

952

Employees952

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

1987

Founded1987

Employees

952

Employees952

NVAX Key Statistics

Market cap

1.28B

Market cap1.28B

Price-Earnings ratio

3.50

Price-Earnings ratio3.50

Dividend yield

—

Dividend yield—

Average volume

7.13M

Average volume7.13M

High today

$7.96

High today$7.96

Low today

$7.66

Low today$7.66

Open price

$7.86

Open price$7.86

Volume

5.45M

Volume5.45M

52 Week high

$15.22

52 Week high$15.22

52 Week low

$5.01

52 Week low$5.01

NVAX News

Seeking Alpha 3d

Novavax gets Japan nod for its COVID-19 vaccine, triggers Takeda payment

Novavax (NASDAQ:NVAX) has received regulatory approval in Japan for its COVID-19 vaccine, Nuvaxovid, which has resulted in a milestone payment from Takeda (NYSE...

TipRanks 3d

Novavax’s COVID-19 vaccine Nuvaxovid approved in Japan

Novavax (NVAX) announced a milestone payment from Takeda (TAK) has been triggered by regulatory approval for Novavax’s COVID-19 vaccine Nuvaxovid Intramuscular...

TipRanks 3d

Novavax ‘applauds’ President Trump’s call for available COVID-19 vaccine data

Novavax (NVAX) issued the following statement on publicly available COVID-19 vaccine data: “Novavax is a U.S.-based biotechnology company that is proud to have...

Analyst ratings

50%

of 8 ratings

Buy

50%

Hold

12.5%

Sell

37.5%

More NVAX News

Simply Wall St 4d

Should US FDA Approval of Updated Nuvaxovid Spur Action From Novavax Investors?

On August 27, 2025, Novavax announced that the U.S. FDA approved the Nuvaxovid 2025-2026 formula for COVID-19 prevention in adults 65 and older, as well as indi...

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.